NO135938B - - Google Patents
Download PDFInfo
- Publication number
- NO135938B NO135938B NO3751/69A NO375169A NO135938B NO 135938 B NO135938 B NO 135938B NO 3751/69 A NO3751/69 A NO 3751/69A NO 375169 A NO375169 A NO 375169A NO 135938 B NO135938 B NO 135938B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- compound
- group
- acid
- ester
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims description 66
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 50
- 239000002253 acid Substances 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 36
- 150000003839 salts Chemical class 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 21
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 229910052783 alkali metal Inorganic materials 0.000 claims description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 12
- 150000001340 alkali metals Chemical class 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 238000000197 pyrolysis Methods 0.000 claims description 4
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 claims description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 238000006136 alcoholysis reaction Methods 0.000 claims description 2
- 238000007098 aminolysis reaction Methods 0.000 claims description 2
- 238000005915 ammonolysis reaction Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000002524 organometallic group Chemical group 0.000 claims description 2
- 125000004043 oxo group Chemical group O=* 0.000 claims description 2
- 230000008707 rearrangement Effects 0.000 claims description 2
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- UAYNGKUREOMISV-UHFFFAOYSA-N 2-(2,3-dihydro-1H-isoindol-1-yl)-2-phenylpropanoic acid Chemical class C1(NCC2=CC=CC=C12)C(C(=O)O)(C)C1=CC=CC=C1 UAYNGKUREOMISV-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 71
- -1 alkyl zinc Chemical compound 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
- 239000000243 solution Substances 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- 239000000284 extract Substances 0.000 description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- 239000007858 starting material Substances 0.000 description 22
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000002844 melting Methods 0.000 description 17
- 230000008018 melting Effects 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- 150000007513 acids Chemical class 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 150000004820 halides Chemical class 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000013067 intermediate product Substances 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 6
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 5
- 229910052744 lithium Inorganic materials 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- KGKAYWMGPDWLQZ-UHFFFAOYSA-N 1,2-bis(bromomethyl)benzene Chemical group BrCC1=CC=CC=C1CBr KGKAYWMGPDWLQZ-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 4
- 150000001342 alkaline earth metals Chemical class 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 4
- 229910052793 cadmium Chemical class 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 239000011701 zinc Chemical class 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 3
- 229940092714 benzenesulfonic acid Drugs 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- JNGYSRUHXIWYOP-UHFFFAOYSA-N 2-(4-aminophenyl)propan-1-ol Chemical compound OCC(C)C1=CC=C(N)C=C1 JNGYSRUHXIWYOP-UHFFFAOYSA-N 0.000 description 2
- AOTLWDQSZSDCEF-UHFFFAOYSA-N 2-(4-bromophenyl)-1,3-dihydroisoindole Chemical compound C1=CC(Br)=CC=C1N1CC2=CC=CC=C2C1 AOTLWDQSZSDCEF-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical class [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 150000008049 diazo compounds Chemical class 0.000 description 2
- MOUBYACUXWWHSC-UHFFFAOYSA-N diethyl 2-methyl-2-(4-nitrophenyl)propanedioate Chemical compound CCOC(=O)C(C)(C(=O)OCC)C1=CC=C([N+]([O-])=O)C=C1 MOUBYACUXWWHSC-UHFFFAOYSA-N 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- OXCVINCJTRJKKQ-UHFFFAOYSA-N ethyl 2-(4-aminophenyl)propanoate;hydrochloride Chemical compound Cl.CCOC(=O)C(C)C1=CC=C(N)C=C1 OXCVINCJTRJKKQ-UHFFFAOYSA-N 0.000 description 2
- QQOVRPBUAUNBAV-UHFFFAOYSA-N ethyl 2-(chloromethyl)benzoate Chemical compound CCOC(=O)C1=CC=CC=C1CCl QQOVRPBUAUNBAV-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N hydroxymethyl benzene Natural products OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- UCMNMOLVECBPHY-UHFFFAOYSA-N n-(4-prop-1-en-2-ylphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(C(C)=C)C=C1 UCMNMOLVECBPHY-UHFFFAOYSA-N 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 125000003431 oxalo group Chemical group 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 150000003556 thioamides Chemical class 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- CZGCEKJOLUNIFY-UHFFFAOYSA-N 4-Chloronitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C=C1 CZGCEKJOLUNIFY-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 238000006218 Arndt-Eistert homologation reaction Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- YECPNDCQJXCNME-UHFFFAOYSA-N CCOC(C(C)C(C=C1)=CC=C1N1CC2=CC=CC=C2C1)=O Chemical compound CCOC(C(C)C(C=C1)=CC=C1N1CC2=CC=CC=C2C1)=O YECPNDCQJXCNME-UHFFFAOYSA-N 0.000 description 1
- SOCPHAQYFATGGB-UHFFFAOYSA-N CC[Cd] Chemical group CC[Cd] SOCPHAQYFATGGB-UHFFFAOYSA-N 0.000 description 1
- JQOATXDBTYKMEX-UHFFFAOYSA-N CC[Zn] Chemical compound CC[Zn] JQOATXDBTYKMEX-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- KKQVGENVCFVFHF-UHFFFAOYSA-M I[Mg] Chemical compound I[Mg] KKQVGENVCFVFHF-UHFFFAOYSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- 239000004157 Nitrosyl chloride Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 238000005672 Willgerodt-Kindler rearrangement reaction Methods 0.000 description 1
- 238000006044 Wolff rearrangement reaction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- WCTKUENARPWTAY-UHFFFAOYSA-N ac1l9mss Chemical class OS(Cl)=O WCTKUENARPWTAY-UHFFFAOYSA-N 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical class B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-M chlorate Inorganic materials [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 230000020176 deacylation Effects 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- 230000006324 decarbonylation Effects 0.000 description 1
- 238000006606 decarbonylation reaction Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000001993 dermatopathological effect Effects 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical group CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- ARFLASKVLJTEJD-UHFFFAOYSA-N ethyl 2-bromopropanoate Chemical compound CCOC(=O)C(C)Br ARFLASKVLJTEJD-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000011491 glass wool Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000005911 haloform reaction Methods 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000002641 lithium Chemical group 0.000 description 1
- BLQJIBCZHWBKSL-UHFFFAOYSA-L magnesium iodide Chemical compound [Mg+2].[I-].[I-] BLQJIBCZHWBKSL-UHFFFAOYSA-L 0.000 description 1
- 229910001641 magnesium iodide Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 1
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- VPCDQGACGWYTMC-UHFFFAOYSA-N nitrosyl chloride Chemical compound ClN=O VPCDQGACGWYTMC-UHFFFAOYSA-N 0.000 description 1
- 235000019392 nitrosyl chloride Nutrition 0.000 description 1
- NSDWWGAIPUNJAX-UHFFFAOYSA-N o-quinomethane Chemical group C=C1C=CC=CC1=O NSDWWGAIPUNJAX-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- OJPNKYLDSDFUPG-UHFFFAOYSA-N p-quinomethane Chemical group C=C1C=CC(=O)C=C1 OJPNKYLDSDFUPG-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008379 phenol ethers Chemical class 0.000 description 1
- 150000004707 phenolate Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- XMXNVYPJWBTAHN-UHFFFAOYSA-N potassium chromate Chemical class [K+].[K+].[O-][Cr]([O-])(=O)=O XMXNVYPJWBTAHN-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- UJTRRNALUYKHQE-UHFFFAOYSA-N sodium;diphenylmethylbenzene Chemical compound [Na+].C1=CC=CC=C1[C-](C=1C=CC=CC=1)C1=CC=CC=C1 UJTRRNALUYKHQE-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 125000004953 trihalomethyl group Chemical group 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
- C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
- C07D207/448—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Abstract
Analogifremgangsmåte til fremstilling av isoindolinyl-fenyl-propion-syreforbindelser.Analogous process for the preparation of isoindolinyl-phenyl-propionic acid compounds.
Description
Gjenstand for patent nr. 132.199 er a-(aminofenyl)-alifatiske karboksylsyrer hvori aminogruppen er en cyklisk terti-ær aminogruppe samt deres syrederivater. Disse forbindelser viser antiinflammatoriske egenskaper og kan anvendes tilsvarende. The subject of patent no. 132,199 are α-(aminophenyl)-aliphatic carboxylic acids in which the amino group is a cyclic tertiary amino group and their acid derivatives. These compounds show anti-inflammatory properties and can be used accordingly.
Det er nå funnet at isoindolinyl-fenyl-propionsyrer med formel It has now been found that isoindolinyl-phenyl-propionic acids of formula
hvori gruppen \^ Jfi betyr en isoindolinogruppe, som eventuelt kan være substituert med 1 oksogruppe, R-^ betyr hydrogen eller eventuelt halogen, eller estere eller salter av slike forbindelser, har spesielt utpregede antiinflammatoriske egenskaper eller på enkel måte lar seg overføre i tilsvarende farmakologisk virksomme forbindelser. in which the group \^ Jfi means an isoindolino group, which can optionally be substituted with 1 oxo group, R-^ means hydrogen or optionally halogen, or esters or salts of such compounds, have particularly pronounced anti-inflammatory properties or can easily be transferred into corresponding pharmacological active compounds.
Uttrykket "lavere" som anvendes ovenfor og nedenfor sammen med organiske radikaler, grupper eller forbindelser betyr at således betegnede organiske radikaler i grupper og forbindelser inneholder inntil 7, fortrinnsvis inntil k karbonatomer. The expression "lower" used above and below together with organic radicals, groups or compounds means that organic radicals thus designated in groups and compounds contain up to 7, preferably up to k carbon atoms.
Estere er f.eks. laverealkylestere, salter er f.eks. ammonium- eller metallsalter, samt syreaddisjonssalter. Esters are e.g. lower alkyl esters, salts are e.g. ammonium or metal salts, as well as acid addition salts.
De betennelsesmotvirkende egenskaper kan påvises ved hjelp av dyreforsøk hvortil man fortrinnsvis bruker pattedyr som rotter som forsøksdyr. Ifølge den forsøksmetode som f.eks. er beskrevet av Winter og medarbeidere i Proe.Soc.Exptl.Biol. The anti-inflammatory properties can be demonstrated using animal experiments, for which mammals such as rats are preferably used as experimental animals. According to the test method that e.g. is described by Winter and co-workers in Proe.Soc.Exptl.Biol.
& Med., bind 111, side 5^4 (1962), gis forbindelsene i henhold til foreliggende oppfinnelse i form av vandige oppløsninger eller suspensjoner inneholdende f.eks. karboksymetylcellulose eller & Med., volume 111, page 5^4 (1962), the compounds according to the present invention are provided in the form of aqueous solutions or suspensions containing e.g. carboxymethylcellulose or
polyetylenglykol som oppløsningsformidlere, ved hjelp av magesonder til voksne han- og hunrotter i dagsdoser på ca. 0,0001 til ca. 0,075 g/kg, fortrinnsvis i doser på mellom 0,0005 og 0,05 g/kg og i første rekke i doser på mellom ca. 0,001 og omtrent 0,025 g/kg. Omtrent en time senere injiseres 0,06 ml 1%-ig carrageeninsuspensjon i vandig fysiologisk saltoppløsning i forsøksdyrets venstre bakben. Etter 3-4 timer sammenlignes volum og/eller vekt av det ødemiske venstre bakben med disse data for det høyre bakben. Forskjellen mellom de to ekstremi-teter sammenlignes med forskjellene mellom størrelsene for ube-handlede kontrolldyr, og sammenligningen tjener som målestokk for'forsøksforbindelsenes antiinflammatoriske virkning. Polyethylene glycol as dissolution mediators, using gastric tubes to adult male and female rats in daily doses of approx. 0.0001 to approx. 0.075 g/kg, preferably in doses of between 0.0005 and 0.05 g/kg and primarily in doses of between approx. 0.001 and about 0.025 g/kg. Approximately one hour later, 0.06 ml of a 1% carrageenan suspension in aqueous physiological salt solution is injected into the left hind leg of the experimental animal. After 3-4 hours, the volume and/or weight of the edematous left hind leg is compared with these data for the right hind leg. The difference between the two extremities is compared with the differences between the sizes for untreated control animals, and the comparison serves as a benchmark for the anti-inflammatory effect of the test compounds.
Det ble undersøkt og sammenlignet den antiinflammatoriske virkning av'følgende forbindelser: I a-/<->3-klor-4-(l-okso-2-isoindolinyl)-fenylV-propion syre (ifølge oppfinnelsen) The anti-inflammatory effect of the following compounds was examined and compared: acid (according to the invention)
II a-/~4-(l-okso-2-isoindolinyl)-fenylZ-propionsyre II α-[4-(1-oxo-2-isoindolinyl)-phenylZ-propionic acid
(ifølge oppfinnelsen) (according to the invention)
III a-//~3~klor-4- (2-isoindolinyl) -f enylj-propionsyre III a-//~3~chloro-4-(2-isoindolinyl)-phenylj-propionic acid
(ifølge oppfinnelsen) (according to the invention)
IV 2-/~p-(l-pyrryl)-fenyl7-propionsyre (kjent) IV 2-/~p-(1-pyrryl)-phenyl7-propionic acid (known)
Den terapeutiske indeks av de ifølge oppfinnelsen fremstillbare forbindelser I - III er tydelig vesentlig større enn for sammenligningsforbihdelsen IV. Det kan hermed henvises til en overlegen antiinflammatorisk virkning.i forhold til den kjente forbindelse. The therapeutic index of the compounds I - III which can be prepared according to the invention is clearly significantly greater than that of the comparison compound IV. Reference can be made to a superior anti-inflammatory effect compared to the known compound.
I henhold til den utviklede adjuvans-artritistest beskrevet av Newbould, Brit.J. PharmacolChemotherap., bind 21, side 126 (1963), sensitiveres1rotter under eterbedøvelse med 0,05 ml l#-ig vandig carrageeninsuspensjon på alle 4 ben. Etter 24 timer injiseres 0,1 ml 1%- ig, suspensjon mycobacterium butyricum under halehuden. Forsøksforbindelsene gis etter 7 dager på ovennevnte måte i lk dager ved hjelp av magesonder. Rottene veies en gang i uken,og de sekundære artritiske lesjoner be-stemmes tre ganger i uken i antall og størrelse. According to the developed adjuvant arthritis test described by Newbould, Brit.J. PharmacolChemotherap., vol. 21, page 126 (1963), sensitized 1 rats under ether anesthesia with 0.05 ml 1#-ig aqueous carrageenin suspension on all 4 legs. After 24 hours, 0.1 ml of a 1% suspension of mycobacterium butyricum is injected under the tail skin. The test compounds are given after 7 days in the above-mentioned manner for 1k days by means of gastric tubes. The rats are weighed once a week, and the secondary arthritic lesions are determined three times a week in number and size.
Foreliggende oppfinnelses forbindelser kan således benyttes som antiinflammatoriske midler ved behandlingen av artritiske og dermapatologiske sykdommer. The compounds of the present invention can thus be used as anti-inflammatory agents in the treatment of arthritic and dermatopathological diseases.
Fremgangsmåten ifølge oppfinnelsen er karakterisert ved at The method according to the invention is characterized in that
a) en forbindelse med formel a) a compound with formula
hvori Xp betyr en primær aminogruppe eller en ester herav, wherein Xp means a primary amino group or an ester thereof,
omsettes med en forbindelse med formel is reacted with a compound of formula
hvori den bivalente rest A med et nitrogenatom har den i gruppen A^^N ovenfor angitte betydning, eller et reaksjonsdyktig derivat herav eller et tilsvarende dehydratisert derivat herav, eller in which the bivalent residue A with a nitrogen atom has the meaning given in the group A^^N above, or a reactive derivative thereof or a corresponding dehydrated derivative thereof, or
b) en forbindelse med formel b) a compound of formula
hvori X^ betyr et hydrogenatom, omsettes etter Friedel-Crafts-reaksjon med en forbindelse med formel in which X^ denotes a hydrogen atom, is reacted by Friedel-Crafts reaction with a compound of formula
eller en ester hvori Y-^ betyr et halogenatom, eller or an ester in which Y-^ means a halogen atom, or
c) en forbindelse med formel IV omsettes med en forbindelse med formel c) a compound of formula IV is reacted with a compound of formula
eller en ester, idet en av gruppene X-, og betyr et halogenatom og den andre betyr et alkalimetall eller metallorganisk gruppering, eller d) en forbindelse med formel IV, hvori X-^ betyr grupperingen méd formel hvori Y£ betyr en metallisk rest, omsettes med et metallfritt, reaksjonsdyktig derivat av karbon- eller maursyre, eller e) en forbindelse med formel IV, hvori X.^ betyr grupperingen med formel hvori Y2 betyr en ammoniumgruppe eller en fri hydroksygruppe eller et halogenatom omsettes med et metållcyanid, eller f) i en forbindelse med formel IV, hvori X.^ betyr grupperingen med formel hvori betyr en metylgruppe, omdannes Y^ ved oksydasjon eller omleiring i en fri karboksygruppe, eller g) i en forbindelse med formel IV, hvori X]_ betyr en fri eller en i esterform foreliggende gruppe med formel or an ester, wherein one of the groups X-, and means a halogen atom and the other means an alkali metal or organometallic grouping, or d) a compound of formula IV, in which X-^ means the grouping with formula in which Y£ means a metallic residue, is reacted with a metal-free, reactive derivative of carbonic or formic acid, or e) a compound of formula IV, in which X.^ means the grouping of formula in which Y2 means an ammonium group or a free hydroxy group or a halogen atom is reacted with a metal cyanide, or f) in a compound of formula IV, in which X.^ means the grouping of formula in which means a methyl group, Y^ is converted by oxidation or rearrangement into a free carboxy group, or g) in a compound of formula IV, in which X]_ means a free or a group with formula present in ester form
hvori Yjj betyr en karboksygruppe, avspaltes Y^ ved pyrolyse, eller in which Yjj means a carboxy group, Y^ is split off by pyrolysis, or
h) en forbindelse med formel IV, hvori X^ betyr en acetylgruppe, behandles med svovel i nærvær av ammoniakk eller h) a compound of formula IV, in which X^ represents an acetyl group, is treated with sulfur in the presence of ammonia or
et primært eller sekundært amin, eller a primary or secondary amine, or
i) en forbindelse med formel IV, hvori X-^ betyr en gruppering med formel i) a compound of formula IV, wherein X-^ means a grouping of formula
omdannes ved hydrolyse,, alkoholyse, ammonolyse eller aminolyse, eller j) en forbindelse med formel IV, hvori X-^ betyr en gruppering med formel converted by hydrolysis, alcoholysis, ammonolysis or aminolysis, or j) a compound of formula IV, in which X-^ means a grouping of formula
hvori Hal betyr et halogenatom, behandles med et sterkt alkalisk middel eller et oppløselig sølvsalt, wherein Hal means a halogen atom, is treated with a strong alkaline agent or a soluble silver salt,
og/eller en dannet ester eller et dannet salt med et hydrogenatom i a-stilling metalliseres eller omsettes med en reaksjonsdyktig ester av en alkohol med formel R^-OH og/eller dannede forbindelser halogenerer den aromatiske rest Ph og/eller, hvis ønskelig, overføres en dannet fri forbindelse i et salt eller et dannet salt i den fri forbindelse og/eller, hvis ønskelig, oppdeles en dannet isomerblanding i de enkelte.isomere. and/or a formed ester or a formed salt with a hydrogen atom in the α-position is metallized or reacted with a reactive ester of an alcohol of the formula R^-OH and/or compounds formed halogenate the aromatic residue Ph and/or, if desired, a formed free compound is transferred into a salt or a formed salt in the free compound and/or, if desired, a formed isomer mixture is divided into the individual isomers.
En metallholdig gruppe eller metallgruppe utgjøres f.eks. av et alkalimetallatom som litiumatom, eller et substituert jordalkali-metall-, sink- eller kadmiumatom som halogen-magnesiumgruppe, eller en lavalkyl-sink- eller lavalkyl-kadmium-, f.eks. klor-, brom- eller jodmagnesium- eller også metyl- eller etylsink- eller metyl- eller etyl-kadmiumgruppe. En reaktivt forestret hydroksylgruppe utgjøres fortrinnsvis av en hydroksylgruppe som er forestret med en sterk mineralsyre eller sulfonsyre f.eks. hydrogenhalogenidsyre, svovelsyre, 1 valkansulfonsyre eller benzensulfonsyre, f.eks. saltsyre, bromsyre, metansulfonsyre, etansulfonsyre, benzensulfonsyre eller p-toluensulfonsyre. A metal-containing group or metal group is e.g. of an alkali metal atom such as a lithium atom, or a substituted alkaline earth metal, zinc or cadmium atom such as a halogen-magnesium group, or a lower alkyl zinc or lower alkyl cadmium, e.g. chlorine, bromine or iodomagnesium or also methyl or ethyl zinc or methyl or ethyl cadmium group. A reactively esterified hydroxyl group is preferably formed by a hydroxyl group which is esterified with a strong mineral acid or sulphonic acid, e.g. hydrohalic acid, sulfuric acid, 1 valcanesulfonic acid or benzenesulfonic acid, e.g. hydrochloric acid, bromic acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid or p-toluenesulfonic acid.
Priedel-Crafts-reaksjonen gjennomføres i nærvær av' en Lewissyre som f.eks. et aluminiumsalt, eller bor-, antimon-V-, jern-II- eller sinksalt, særlig -klorider, eller i nærvær The Priedel-Crafts reaction is carried out in the presence of a Lewis acid such as e.g. an aluminum salt, or boron, antimony-V, iron-II or zinc salt, especially chlorides, or in the presence
av flussyre, svovelsyre eller fortrinnsvis polyfosforsyre, hvorved sistnevnte i første rekke anvendes sammen med forbindelser med formel IVb eller derivater av denne hvor,. Y-^ betegner en hydroksylgruppe. of hydrofluoric acid, sulfuric acid or preferably polyphosphoric acid, whereby the latter is primarily used together with compounds of formula IVb or derivatives thereof where, Y-^ denotes a hydroxyl group.
I en gruppering med formel -CHCCH^O-Yg (IVc) kan en metallisk rest Yg-f.eks. bety en av de overnevnte rester, videre betyr en ammoniumgruppe f.eks. en trilaverealkyl-ammonium- eller dilaverealkyl-ary1-laverealky1-ammonium-, f.eks. trimetylammonium-eller dimetylbenzylammoniumgruppe, mens en funksjonelt modifi-sert hydroksygruppe, f.eks. en forestret hydroksygruppe som en av de overnevnte, forestrede hydroksygrupper, en foretret hydroksygruppe f.eks. en med en laverealkanol eller en aryl-laverealkanol foretret hydroksygruppe eller en i saltform foreliggende hydroksygruppe, f.eks. en med et alkali- eller jordalkalimetall, f.eks. natrium, kalium eller kalsium, i en tilsvarende saltgruppering omdannet hydroksygruppe. In a grouping with the formula -CHCCH^O-Yg (IVc), a metallic residue Yg-e.g. means one of the above-mentioned residues, further means an ammonium group e.g. a tri-lower alkyl-ammonium or di-lower alkyl-aryl-lower alkyl-ammonium, e.g. trimethylammonium or dimethylbenzylammonium group, while a functionally modified hydroxy group, e.g. an esterified hydroxy group such as one of the above-mentioned esterified hydroxy groups, an esterified hydroxy group e.g. a hydroxy group etherified with a lower alkanol or an aryl-lower alkanol or a hydroxy group present in salt form, e.g. one with an alkali or alkaline earth metal, e.g. sodium, potassium or calcium, in a corresponding salt group converted hydroxy group.
En metall- eller Grignardforbindelse med formel IV kan omsettes med et egnet metallfritt karboksylsyrederivat eller maursyrederivat, fortrinnsvis med karbondioksyd, eller med et tilsvarende karbonat eller halogenmaursyreester som f.eks. di-etylkarbonat, orotmaursyre-lavalkyl-, som f.eks. -etylester eller -propylester, halogenmaursyre-lavalkyl-, -fenyl- eller -fenyl-lavalkylester, hvori en lavalkylfenyl- eller fenyl-lavalkylester eventuelt kan være substituert, som f.eks. klor-maursyre-etylester, -t.-butylester, -allylester, -2-metoksyetyl-ester, -fenylester eller -benzylester, eller med halogencyan eller karbamoylhalogenid, f.eks. bromcyan eller dietylkarbamoyl-klorid. A metal or Grignard compound of formula IV can be reacted with a suitable metal-free carboxylic acid derivative or formic acid derivative, preferably with carbon dioxide, or with a corresponding carbonate or halogen formic acid ester such as e.g. diethyl carbonate, orotformic acid-lower alkyl-, such as e.g. -ethyl ester or -propyl ester, haloformic acid-lower alkyl-, -phenyl- or -phenyl-lower alkyl ester, in which a lower alkyl phenyl or phenyl lower alkyl ester may optionally be substituted, such as e.g. chloroformic acid ethyl ester, -t-butyl ester, -allyl ester, -2-methoxyethyl ester, -phenyl ester or -benzyl ester, or with halocyano or carbamoyl halide, e.g. cyanogen bromide or diethylcarbamoyl chloride.
Et utgangsstoff .med formel IV med en gruppe med formel IVc, hvori Y2 betegner en ammoniumgruppe eller en fri eller reaktivt funksjonelt omdannet hydroksylgruppe, særlig forestret eller foretret hydroksylgruppe, omsettes med et metallcyanid som alkalimetallcyanid av typen natrium- eller kaliumcyanid. Et utgangsstoff hvori Y2 i en gruppe med formel IVc be.t-egner en fri forestret eller forsaltet hydroksylgruppe eller en tilsvarende dehydratisert forbindelse méd formel IV hvori X-^ betegner en 1-lavalkenylrest, kan også omsettes med karbon-monoksyd. Sistnevnte omsetning skjer i nøytralt, basisk eller surt miljø, og f.eks. i nærvær av svovelsyre og under høyt trykk og temperatur, f.eks. ved opptil 400 atmosfærer og 300°C, og fortrinnsvis i nærvær av tungmetallkatalysator som nikkel- eller koboltsalter eller et karbonylderivat av denne. Karbonmonok- A starting material of formula IV with a group of formula IVc, in which Y2 denotes an ammonium group or a free or reactively functionally converted hydroxyl group, in particular an esterified or etherified hydroxyl group, is reacted with a metal cyanide such as an alkali metal cyanide of the sodium or potassium cyanide type. A starting substance in which Y2 in a group of formula IVc is a free esterified or salted hydroxyl group or a corresponding dehydrated compound with formula IV in which X-^ denotes a 1-alkenyl residue can also be reacted with carbon monoxide. The latter turnover takes place in a neutral, basic or acidic environment, and e.g. in the presence of sulfuric acid and under high pressure and temperature, e.g. at up to 400 atmospheres and 300°C, and preferably in the presence of heavy metal catalyst such as nickel or cobalt salts or a carbonyl derivative thereof. carbon monoc-
syd kan også utvikles av egnede reagenser som f.eks. maursyre i nærvær av høytkokende mineralsyrer som svovelsyre og fosforsyre. syd can also be developed by suitable reagents such as e.g. formic acid in the presence of high-boiling mineral acids such as sulfuric and phosphoric acid.
I et tilsvarende utgangsstoff med formel IV med en gruppering med formel IVd, hvori Y^ utgjør en potensiell karboksylgruppe, kan Y^ overføres til en fri eller funksjonelt omdannet karboksylgruppe ved hjelp av standard oksydasjonsmetoder, f.eks. ved behandling med oksygen (enten i ren form eller i form av luft), fortrinnsvis i nærvær av egnet katalysator som sølv-, mangan-, jern-, eller koboltkatalysator, eller med oksydasjons-midler som hydrogenperoksyd, eller' med et nitrogenoksyd, oksy- , derende syrer eller salter av disse som f.eks. oksyhalogensyrer, perjodsyre, salpetersyre eller perkarbonsyrer eller tilsvarende salter som f.eks. alkalimetallsalter av typen natriumhypoklorit eller natriumperjodat, pereddiksyre, perbenzosyre eller raono-perftalsyre, tungmetallsalter eller -oksyder som alkalimetall-f.eks. natrium- eller kaliumkromater eller -permanganater, krom-III- eller kobber-II-salter, f.eks. -halogenider eller -sulfater, eller sølv-, kvikksølv-, vanadium-V-, krom-VI- eller mangan-IV-oksyder, i surt eller alkalisk medium. Vanligvis får man ifølge ovenstående oksydasjonsmetoder som produkter de frie syrer med formel I eller salter av disse. In a corresponding starting material of formula IV with a grouping of formula IVd, in which Y^ constitutes a potential carboxyl group, Y^ can be transferred to a free or functionally converted carboxyl group by means of standard oxidation methods, e.g. by treatment with oxygen (either in pure form or in the form of air), preferably in the presence of a suitable catalyst such as a silver, manganese, iron or cobalt catalyst, or with oxidizing agents such as hydrogen peroxide, or with a nitrogen oxide, oxy - , derating acids or salts thereof such as e.g. oxyhalogenic acids, periodic acid, nitric acid or percarboxylic acids or corresponding salts such as e.g. alkali metal salts of the type sodium hypochlorite or sodium periodate, peracetic acid, perbenzoic acid or raonoperphthalic acid, heavy metal salts or oxides such as alkali metal-e.g. sodium or potassium chromates or permanganates, chromium III or copper II salts, e.g. -halides or -sulphates, or silver, mercury, vanadium-V, chromium-VI or manganese-IV oxides, in acidic or alkaline medium. Generally, according to the above oxidation methods, the free acids of formula I or their salts are obtained as products.
Et utgangsstoff med ovenstående gruppe av formel IVd hvori Y-j betegner en eventuelt funksjonelt omdannet og særlig forestret karboksykarbonyl- som karbo-lavalkoksykarbonylgruppe, kan overføres til den ønskede forbindelse med formel I ved oksydasjon med f.eks. hydrogenperoksyd i surt miljø, f.eks. under tilsetning av mineralsyre, eller ved dekarbonylering i første rekke ved hjelp av pyrolyse, fortrinnsvis i nærvær av kobber-eller glasspulver. A starting material with the above group of formula IVd in which Y-j denotes an optionally functionally converted and particularly esterified carboxycarbonyl such as carbo-la carboxycarbonyl group, can be transferred to the desired compound of formula I by oxidation with e.g. hydrogen peroxide in an acidic environment, e.g. with the addition of mineral acid, or by decarbonylation primarily by means of pyrolysis, preferably in the presence of copper or glass powder.
I en slik rest med formel -C(CH5) (Y4)-C(=0)-OH (IVf) overføres resten Yj| til gruppen CH-j sammen med hydrogen, ved reduksjon, dekarboksylering, deacylering eller desulfurering. In such a residue of formula -C(CH5) (Y4)-C(=0)-OH (IVf) the residue Yj| to the group CH-j together with hydrogen, by reduction, decarboxylation, deacylation or desulphurisation.
Hvis Yfj betegner en karboksylgruppe og hvis utgangsstoff et er et tilsvarende malonsyrederivat, kan et slikt utgangsstoff dekarboksyleres ved pyrolyse, fortrinnsvis i surt miljø. Hvis Yjj står for en annen acylgruppe som lavalkanoyl-, aroyl-eller aryllavalkanoyl- f.eks. acetyl- eller benzoylgruppe, kan mån syrespalte det tilsvarende B-ketosyre-utgangsstoff ved inn-virkning av et sterkt alkalisk reagens som f.eks. et av ovenstående alkalimetallhydroksyder. If Yfj denotes a carboxyl group and if the starting material is a corresponding malonic acid derivative, such a starting material can be decarboxylated by pyrolysis, preferably in an acidic environment. If Yjj stands for another acyl group such as lower alkanoyl, aroyl or aryl alkanoyl, e.g. acetyl or benzoyl group, the corresponding B-keto acid starting material can be cleaved by acid under the influence of a strong alkaline reagent such as e.g. one of the above alkali metal hydroxides.
I et utgangsstoff med formel III kan Xn f.eks. be-tegne et hydrogenatom, eller en metallholdig gruppe eller en eventuelt reaktivt forestret hydroksylgruppe som ovenstående definerte grupper, fortrinnsvis for et alkalimetall- eller halogenatom. Det tilsvarende utgangsstoff med formel III kan omsettes med en forbindelse med formel r\~ Yc (Ula), hvorved en av restene Xg og Yg betegner et hydrogenatom eller nevnte metallholdige gruppe, f.eks. litium eller natrium., og den andre står for en fri eller reaktivt forestret hydroksylgruppe,. f.eks. In a starting substance with formula III, Xn can e.g. denote a hydrogen atom, or a metal-containing group or an optionally reactive esterified hydroxyl group such as the groups defined above, preferably for an alkali metal or halogen atom. The corresponding starting material of formula III can be reacted with a compound of formula r\~ Yc (Ula), whereby one of the residues Xg and Yg denotes a hydrogen atom or said metal-containing group, e.g. lithium or sodium., and the other stands for a free or reactively esterified hydroxyl group,. e.g.
et fluor- eller kloratom. a fluorine or chlorine atom.
Hvis X2 betegner hydrogen og Yg står for et halogenatom, gjennomføres reaksjonen analogt med ovenstående Friedel-Crafts-reaksjon, f.eks. i nærvær av en Lewissyre, eller hvis Yg betegner en hydroksylgruppe i nærvær av et alkalisk reagens som kaliumhydroksyd. Hvis X2 betyr en hydroksy- eller lavalkanoyl-oksygruppe, arbeides fortrinnsvis i nærvær av et dehydratiser-ings- eller dehydrogeneringsmiddel, som f.eks. en mineralsyre eller et mineralsyresalt, eksempelvis saltsyre, ammoniumsulfitt eller natriumhydrogensulfitt, aktivert aluminiumoksyd, Raney-nikkel eller palladium/kull. Et halogenatom X2 utgjøres fortrinnsvis av et fluoratom. If X2 denotes hydrogen and Yg stands for a halogen atom, the reaction is carried out analogously to the above Friedel-Crafts reaction, e.g. in the presence of a Lewis acid, or if Yg denotes a hydroxyl group in the presence of an alkaline reagent such as potassium hydroxide. If X2 means a hydroxy or lower alkanoyloxy group, work is preferably carried out in the presence of a dehydrating or dehydrogenating agent, such as e.g. a mineral acid or a mineral acid salt, for example hydrochloric acid, ammonium sulphite or sodium hydrogen sulphite, activated aluminum oxide, Raney nickel or palladium/coal. A halogen atom X2 is preferably constituted by a fluorine atom.
Et utgangsstoff med formel II hvori X2 betegner en primær aminogruppe kan omsettes med en glykol-, glykolsyre- A starting substance of formula II in which X2 denotes a primary amino group can be reacted with a glycol, glycolic acid
eller dikarboksylsyreforbindelse med formel HO-A-OH (III) or dicarboxylic acid compound of formula HO-A-OH (III)
eller fortrinnsvis med et reaktivt derivat som f.eks. en reaktiv ester, eksempelvis halogenhydrogensyre, eller en cyklisk eter av en hydroksylforbindelse med formel III, eller med et tilsvarende dehydratisert derivat av en slik forbindelse, videre med et lakton av en hydroksysyreforbindelse med formel III or preferably with a reactive derivative such as e.g. a reactive ester, for example halohydrogen acid, or a cyclic ether of a hydroxyl compound of formula III, or with a corresponding dehydrated derivative of such a compound, further with a lactone of a hydroxy acid compound of formula III
eller et halogenid eller anhydrid av en syre med formel III. Reaksjonen gjennomføres fortrinnsvis i nærvær av vann eller et syretiltrekkende reagens, f.eks. et alkalimetallkarbonat, addi-sjonen av en umettet forbindelse gjennomføres fortrinnsvis i nærvær av en katalysator som kobber-, kobolt- eller molybden-katalysator, eller i nærvær av et alkalimetall eller tilsvarende hydroksyd. or a halide or anhydride of an acid of formula III. The reaction is preferably carried out in the presence of water or an acid-attracting reagent, e.g. an alkali metal carbonate, the addition of an unsaturated compound is preferably carried out in the presence of a catalyst such as a copper, cobalt or molybdenum catalyst, or in the presence of an alkali metal or corresponding hydroxide.
Fremstilte frie syrer med alkoholer i nærvær av for-estringsreagenser som sterke syrer, f.eks. saltsyre, svovelsyre, benzensulfonsyre eller p-toluensulfonsyre, eller dicykloheksyl-karbodiimid eller med diazoforbindelser, eller overføre forbindelsene til syrehalogenider f.eks. ved behandling med tionylhalogenider som tionylklorid eller fosforhalogenider eller -oksy-halogenider som -klorid eller -oksyklorid. Prepared free acids with alcohols in the presence of esterification reagents such as strong acids, e.g. hydrochloric acid, sulfuric acid, benzenesulfonic acid or p-toluenesulfonic acid, or dicyclohexylcarbodiimide or with diazo compounds, or transfer the compounds to acid halides, e.g. by treatment with thionyl halides such as thionyl chloride or phosphorus halides or -oxy-halides such as -chloride or -oxychloride.
Fremstilte estere kan hydrolyseres til frie syrer f.eks. ved behandling med egnede basiske reagenser som vandig alkalimetallhydroksyd, eller omestres med alkoholer i nærvær av syrer eller alkalier som mineralsyrer eller komplekse tungmetall-syrer, eller med alkalimetallkarb'onater eller -alkoholater. Ved behandling med ammoniakk eller tilsvarende aminer kan estere over- Produced esters can be hydrolysed to free acids, e.g. by treatment with suitable basic reagents such as aqueous alkali metal hydroxide, or transesterified with alcohols in the presence of acids or alkalis such as mineral acids or complex heavy metal acids, or with alkali metal carbonates or alcoholates. When treated with ammonia or similar amines, esters can over-
føres til amider. is led to amides.
Fremstilte syrehalogenider kan, alt etter valg av utgangsstoffer og reaksjonsdeltagere, overføres til estere, halogenider, anhydrider, amider, tioamider eller nitriler ved behandling med alkoholer med ammoniakk eller aminer, og fremstilte metall- eller ammoniumsalter med alkoholer eller tilsvarende halogenider som klorider eller bromider, eller tilsvarende klorsulfitter, tionylhalogenider som tionylklorid, fosforpentoksyd, fosforpentasulfid, fosforhalogenider som fosforpentaklorid eller fosforoksyhalogenider som fosforoksyklorid, eller andre acylhalogenider som f.eks. -klorider. Produced acid halides can, depending on the choice of starting materials and reaction participants, be transferred to esters, halides, anhydrides, amides, thioamides or nitriles by treatment with alcohols with ammonia or amines, and prepared metal or ammonium salts with alcohols or corresponding halides such as chlorides or bromides, or corresponding chlorosulfites, thionyl halides such as thionyl chloride, phosphorus pentoxide, phosphorus pentasulfide, phosphorus halides such as phosphorus pentachloride or phosphorus oxyhalides such as phosphorus oxychloride, or other acyl halides such as e.g. -chlorides.
Fremstilte amider eller tioamider (produkter av Will-gerodt-Kindler-reaksjonen) kan hydrolyseres, alkoholiseres eller transamineres i surt eller alkalisk miljø f.eks. ved behandling med vandige mineralsyrer og/eller karboksylsyrer eller med alkalimetallhydroksyder, og videre desulfureres ved behandling med kvikksølv-II-oksyd og lavalkylhalogenider fulgt av hydrolyse. Produced amides or thioamides (products of the Will-gerodt-Kindler reaction) can be hydrolysed, alcoholized or transaminated in an acidic or alkaline environment, e.g. by treatment with aqueous mineral acids and/or carboxylic acids or with alkali metal hydroxides, and further desulphurised by treatment with mercury II oxide and lower alkyl halides followed by hydrolysis.
Fremstilte nitriler kan hydrolyseres eller alkoholiseres f.eks. ved behandling med konsentrert vandige eller al-koholiske syrer eller alkaliske reagenser som alkalimetallhydroksyder eller med alkalisk hydrogenperoksyd. Manufactured nitriles can be hydrolyzed or alcoholized, e.g. by treatment with concentrated aqueous or alcoholic acids or alkaline reagents such as alkali metal hydroxides or with alkaline hydrogen peroxide.
De fremstilte estere, salter eller nitriler hvor en gruppe R-|_ står for et hydrogenatom, kan metalliseres i a-stilling til den frie eller funksjonelt omdannede karboksylgruppe, f.eks. ved behandling med alkalimetaller eller alkalimetallderivater som organiske alkalimetallforbindelser, f.eks. fenyllitium eller tri-fenylmetylnatrium, eller med alkalimetall- som natriumhydrider, -amider eller -alkoholater, og deretter omsettes med en reaktiv ester av en alkohol med formel R-^-OH, f .eks., et tilsvarende halogenid, hvorved en organisk gruppe R-^ innføres i a-stilling. The produced esters, salts or nitriles where a group R-|_ stands for a hydrogen atom, can be metallized in the a-position to the free or functionally converted carboxyl group, e.g. by treatment with alkali metals or alkali metal derivatives such as organic alkali metal compounds, e.g. phenyllithium or tri-phenylmethyl sodium, or with alkali metals such as sodium hydrides, amides or alcoholates, and then reacted with a reactive ester of an alcohol of the formula R-^-OH, e.g., a corresponding halide, whereby an organic group R-^ is introduced in a-position.
Fremstilte forbindelser kan halogeneres i den aromatiske resten, fortrinnsvis med halogen og i nærvær av en Lewissyre som f.eks. jern-III-, aluminium-, antimon-III- eller tinn-IV-halogenider, eller et halogeneringsmiddel som saltsyre-i nærvær av vannstoffperoksyd, eller med et alkalimetallklorat som natriumklorat, et nitrosylhalogenid som nitrosylklorid eller Compounds produced can be halogenated in the aromatic residue, preferably with halogen and in the presence of a Lewis acid such as e.g. iron III, aluminium, antimony III or tin IV halides, or a halogenating agent such as hydrochloric acid - in the presence of hydrogen peroxide, or with an alkali metal chlorate such as sodium chlorate, a nitrosyl halide such as nitrosyl chloride or
-bromid, halogen-, f.eks. bromravsyreimid eller -ftalimid. -bromide, halogen-, e.g. bromosuccinimide or -phthalimide.
I fremstilte fenoliske produkter kan de fenoliske hydroksy- eller merkaptogrupper foretres f.eks. med de tilsvarende metallfenolater som alkalimetallfenolater og -tiofenolater, ved behandling med lavalkyl- eller cykloalkylhalogenider, -sulfater eller -sulfonater. Fremstilte fenoletere kan spaltes f.eks. ved behandling med sterke syrer eller sure salter som bromsyre og eddiksyre, eller sure salter som bromsyre og eddiksyre, eller med pyridinhydroklorid. In manufactured phenolic products, the phenolic hydroxy or mercapto groups can be preferred, e.g. with the corresponding metal phenolates such as alkali metal phenolates and -thiophenolates, by treatment with lower alkyl or cycloalkyl halides, -sulfates or -sulfonates. Produced phenol ethers can be split, e.g. by treatment with strong acids or acid salts such as bromic acid and acetic acid, or acid salts such as bromic acid and acetic acid, or with pyridine hydrochloride.
En fri syre kan overføres til et salt på forøvrig kjent måte f.eks. ved omsetning med omtrent støkiometriske mengder egnede saltdannende reagenser som ammoniakk, et amin eller et alkalimetall- eller jordalkalimetallhydroksyd, -karbonat eller -hydrogenkarbonat. Ammonium- eller metallsalter av denne type kan overføres til den frie syre ved behandling med en syre som saltsyre, svovelsyre eller eddiksyre inntil den nødvend-ige pH er oppnådd. A free acid can be transferred to a salt in otherwise known manner, e.g. by reaction with approximately stoichiometric amounts of suitable salt-forming reagents such as ammonia, an amine or an alkali metal or alkaline earth metal hydroxide, carbonate or bicarbonate. Ammonium or metal salts of this type can be transferred to the free acid by treatment with an acid such as hydrochloric acid, sulfuric acid or acetic acid until the necessary pH is achieved.
En fremstilte basisk forbindelse kan overføres til A basic compound produced can be transferred to
et syreaddisjonssalt, f.eks. ved omsetning med en organisk eller anorganisk syre eller en tilsvarende ioneveksler og isolering av det dannede saltet. Et fremstilt syreaddisjonssalt kan over-føres til den frie forbindelse f.eks. ved behandling med en base som alkalimetallhydroksyd, ammoniakk eller en hydroksylioneveksler. an acid addition salt, e.g. by reaction with an organic or inorganic acid or a corresponding ion exchanger and isolation of the formed salt. A prepared acid addition salt can be transferred to the free compound, e.g. by treatment with a base such as alkali metal hydroxide, ammonia or a hydroxyl ion exchanger.
jrJr
Syreaddisjonssalter som er farmasøytisk brukbare er f.eks. slike med anorganiske syrer som saltsyre, bromsyre, svovelsyre, fosforsyre, salpetersyre eller perklorsyre eller med organiske syrer og--særlig organiske karboksyl- eller sulfonsyrer, som maursyre, eddiksyre, propionsyre, ravsyre, glykolsyre, melkesyre, eplesyre, vinsyre, sitronsyre, askorbinsyre, maleinsyre, hydroksymaleinsyre, pyrodruesyre, fenyleddiksyre, benzosyre, 4-aminobenzosyre, antra-nilsyre, 4-hydroksybenzosyre, salicylsyre, aminosalicylsyre, embonsyre eller nikotinsyre, samt metansulfonsyre, etansulfonsyre, .hydroksyetansulfonsyre, etylensulfonsyre, benzensulfonsyre, halo-genbenzensulfonsyre, toluensulfonsyre, naftalensulfonsyre,. sulfa-nilsyre eller cykloheksylsulfaminsyre. Acid addition salts which are pharmaceutically usable are e.g. those with inorganic acids such as hydrochloric acid, bromic acid, sulfuric acid, phosphoric acid, nitric acid or perchloric acid or with organic acids and--especially organic carboxylic or sulphonic acids, such as formic acid, acetic acid, propionic acid, succinic acid, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid . ,. sulfanilic acid or cyclohexylsulfamic acid.
Disse og andre salter, som f.eks. pikratene, kan også brukes for rensing av de frie forbindelser, idet de frie forbindelser kan overføres til deres salter, disse skilles fra moderluten og opparbeides fra de isolerte salter ved frisetting av forbindelsene. På grunn av den nære sammenheng mellom de nye forbindelser i fri form og i form av salter, omfatter den ené betegnelse også eventuelt den andre i'foreliggende beskrivelse og krav. These and other salts, such as the picrates, can also be used for purification of the free compounds, as the free compounds can be transferred to their salts, these are separated from the mother liquor and processed from the isolated salts by releasing the compounds. Due to the close connection between the new compounds in free form and in the form of salts, the one designation also possibly includes the other in the present description and claims.
De fremstilte isomerblandinger kan skilles i de enkelte isomere på forøvrig kjent måte, f.eks. ved fraksjonert destillasjon eller krystallisasjon og/eller kromatografi. Racemiske produkter kan skilles i de optiske antipoder ved fraksjonert krystallisasjon av blandinger av de diastereoisomere salter, f.eks. med d- eller 1-vinsyre eller med d-a-fenyletyl-amin, d-a-(l-naftyl)-etylamin eller 1-cinchonidin, og eventuell frigjøring av antipodene fra saltene. The produced isomer mixtures can be separated into the individual isomers in otherwise known manner, e.g. by fractional distillation or crystallization and/or chromatography. Racemic products can be separated in the optical antipodes by fractional crystallization of mixtures of the diastereoisomeric salts, e.g. with d- or 1-tartaric acid or with d-α-phenylethylamine, d-α-(l-naphthyl)ethylamine or 1-cinchonidine, and eventual liberation of the antipodes from the salts.
De ovenstående reaksjoner gjennomføres på. forøvrig kjente måter, f.eks. med eller uten fortynningsmidler, og fortrinnsvis slike som er inerte overfor reaksjonsdeltagerne og oppløser disse, om nødvendig i nærvær av katalysatorer, konden-sasjons- eller nøytraliseringsmidler, under inertgassatmosfære som nitrogenatmosfære, under avkjøling eller oppvarming og/eller under forhøyet trykk og temperatur. The above reactions are carried out on otherwise known ways, e.g. with or without diluents, and preferably those which are inert towards the reaction participants and dissolve these, if necessary in the presence of catalysts, condensation or neutralizing agents, under an inert gas atmosphere such as a nitrogen atmosphere, during cooling or heating and/or under elevated pressure and temperature.
Oppfinnelsen omfatter også slike modifikasjoner av ovenstående fremgangsmåter hvorved man som utgangsstoff anvender en forbindelse som fremkommer på ett eller annet av prosessens mellomliggende trinn som mellomprodukt, og gjennomfører det eller de resterende trinn med dette mellomprodukt, eller avbryter fremgangsmåten på et eller annet trinn, eller metoder hvorved utgangsstoffene dannes i reaksjonsmiljøet eller benyttes i form av salter eller reaktive derivater. I de fleste av de'ovenstående oksydasjonsmetoder hvor Y-j overføres til en fri eller funksjonell omdannet karboksylgruppe, vil således de tilsvarende aldehyder hvor Y-j står for en formylgruppe, dannes som mellomprodukter. Videre kan de trihalogenmetylforbindelser som dannes som mellomprodukter f.eks. ved haloformreaksjonen, hydrolyseres til de tilsvarende salter av syrer med formel I under de fremherskende alkaliske forhold. Kvaternære o- eller p-kinonmetidforbindelser kan likeledes dannes under reaksjonen som mellomprodukter fra de tilsvarende utgangsstoffer hvor Y^ utgjør en gruppe med formel Ilf inneholdende en fri eller reaktiv forestret hydroksylgruppe, f. eks. i sterkt surt eller alkalisk miljø. Videre kan a-diazo-ketonene som er fremstilt ifølge Arndt-Eistert-metoden fra syre-halogenidene ved omsetning med diazoforbindelser benyttes direkte videre til Wolff-omleiringen uten isolering. Videre kan det dannes forskjellige mellomprodukter ut fra de forskjellige ut-gangsstof f ene ved oppbygning av. gruppen A^ 11- . Hvis f.eks. gruppen X2 utgjør en primær aminogruppe, og et tilsvarende utgangsstoff omsettes med en glykol med formel III eller et reaktivt funksjonelt derivat av sistnevnte, får man vanligvis et mellomprodukt med en sekundær aminogruppe X2 av formel -NH-A-OH (Ille), eller et reaktivt derivat av denne. The invention also includes such modifications of the above methods whereby one uses as a starting material a compound that appears at one or other of the intermediate steps of the process as an intermediate product, and carries out the remaining step or steps with this intermediate product, or interrupts the method at one or other step, or methods whereby the starting substances are formed in the reaction environment or used in the form of salts or reactive derivatives. In most of the above oxidation methods where Y-j is transferred to a free or functional converted carboxyl group, the corresponding aldehydes where Y-j stands for a formyl group will thus be formed as intermediate products. Furthermore, the trihalomethyl compounds which are formed as intermediate products can e.g. by the haloform reaction, are hydrolyzed to the corresponding salts of acids of formula I under the prevailing alkaline conditions. Quaternary o- or p-quinone methide compounds can likewise be formed during the reaction as intermediate products from the corresponding starting materials where Y^ constitutes a group of formula Ilf containing a free or reactive esterified hydroxyl group, e.g. in strongly acidic or alkaline environments. Furthermore, the α-diazo-ketones which are prepared according to the Arndt-Eistert method from the acid halides by reaction with diazo compounds can be used directly for the Wolff rearrangement without isolation. Furthermore, different intermediate products can be formed from the different starting materials when building up. the group A^ 11- . If e.g. the group X2 constitutes a primary amino group, and a corresponding starting substance is reacted with a glycol of formula III or a reactive functional derivative of the latter, an intermediate product with a secondary amino group X2 of the formula -NH-A-OH (Ille) is usually obtained, or a reactive derivative of this.
Man anvender fortrinnsvis ifølge fremgangsmåten slike utgangsstoffer som fører til de av oppfinnelsens forbindelser som beskrives som særlig verdifulle. According to the method, starting materials are preferably used which lead to the compounds of the invention which are described as particularly valuable.
Utgangsstoffene er kjent, eller kan, når de er nye, fremstilles på kjente måter. Hvis X-^ f.eks. betegner en reaktivt forestret hydroksylgruppe,.kan denne innføres ved halogen-ering eller nitrering, fulgt av reduksjon, diazosering og Sandmeyer-reaksjon. Det fremstilte utgangsstoffet kan derpå over-føres til en metallforbindelse, f.eks. ved omsetning med et alkali- eller jordalkalimetall som litium eller magnesium, The starting materials are known or, when they are new, can be produced in known ways. If X-^ e.g. denotes a reactive esterified hydroxyl group, this can be introduced by halogenation or nitration, followed by reduction, diazosation and the Sandmeyer reaction. The manufactured starting material can then be transferred to a metal compound, e.g. by reaction with an alkali or alkaline earth metal such as lithium or magnesium,
eller med en dilavalkylsink eller -kadmium. or with a dialkyl zinc or cadmium.
Utgangsstoffer hvor Y2 betegner en metallgruppe kan fremstilles., på analog måte, f. eks. ved omsetning av de reaktive estere av en tilsvarende benzylalkoholforbindelse med et alkalimetall eller jordalkalimetall eller med dilavalkyl-sink eller Starting substances where Y2 denotes a metal group can be prepared in an analogous way, e.g. by reaction of the reactive esters of a corresponding benzyl alcohol compound with an alkali metal or alkaline earth metal or with dilower alkyl zinc or
-kadmium. Utgangsstoffer hvor Y2 betegner en ammoniumgruppe, - cadmium. Starting substances where Y2 denotes an ammonium group,
kan fremstilles ut fra de ovenstående reaktive estere ved omsetning med tertiære aminer eller med sekundære aminer, fulgt av kvaternisering av de fremstilte tertiære aminer etter vanlige metoder, f.eks. ved omsetning med lavalkyl- eller aryl-lavalkylhalogenider. can be prepared from the above reactive esters by reaction with tertiary amines or with secondary amines, followed by quaternization of the produced tertiary amines according to usual methods, e.g. by reaction with lower alkyl or aryl lower alkyl halides.
Utgangsstoff er med en gruppe Y-j kan fremstilles ut Starting material with a group Y-j can be produced from
fra de ovenstående utgangsstoffer med metallgruppe Y2 ved behandling med et metylhalogenid, formaldehyd, formylhalogenid, lavalkanal, lavalkenal eller hydroksy-lavalkanal, eller en lavalkanoyl-, lavalkenoyl- eller oksalylhalogenid, hvorved man om ønsket kan dehydratisere de fremstilte alkoholer, f.eks. ved behandling med sure reagenser som svovelsyre eller fosforpentoksyd, og over-føre disse til de tilsvarende umettede forbindelser. Sistnevnte, f.eks. metylenforbindelser, kan omsettes med boraner til boryl-metylforbindelser, mens aldehyder ved behandling med hydroksyl-amin gir det tilsvarende hydroksyiminometyl-, dvs. oksim.forbindelser. from the above starting materials with metal group Y2 by treatment with a methyl halide, formaldehyde, formyl halide, laval channel, low alkenal or hydroxy-laval channel, or a low alkanoyl, low alkenoyl or oxalyl halide, whereby the produced alcohols can be dehydrated if desired, e.g. by treatment with acidic reagents such as sulfuric acid or phosphorus pentoxide, and transfer these to the corresponding unsaturated compounds. The latter, e.g. methylene compounds can be converted with boranes into boryl-methyl compounds, while aldehydes when treated with hydroxylamine give the corresponding hydroxyiminomethyl, i.e. oxime compounds.
Mellomprodukter fremstilt etter ovenstående metoder Intermediates prepared by the above methods
og ut fra de nevnte utgangsstoffer kan også overføres til hverandre innenfor den angitte ramme. and based on the aforementioned starting substances can also be transferred to each other within the specified framework.
De farmakologisk anvendbare forbindelser av foreliggende oppfinnelse kan f.eks. brukes til fremstilling av farmasøytiske preparater hvori en virksom mengde av den aktive forbindelse fore-ligger sammen med anorganiske eller organiske, faste eller flyt-ende, farmasøytisk brukbare bærematerialer og drøyningsmidler som egner seg til enteral, parenteral eller topikal administra-sjon. The pharmacologically usable compounds of the present invention can e.g. is used for the production of pharmaceutical preparations in which an effective amount of the active compound is present together with inorganic or organic, solid or liquid, pharmaceutically usable carrier materials and drench agents suitable for enteral, parenteral or topical administration.
De farmasøytiske preparater fremstilles på forøvrig kjente måter, ved hjelp av vanlige blandings-, granulerings- The pharmaceutical preparations are produced in otherwise known ways, using usual mixing, granulating,
og drageringsmetoder, og inneholder mellom ca. 0,1 og 75$, spesielt mellom ca. 1 og 50% av de aktive forbindelser og kan om ønsket inneholde andre farmasøytisk aktive forbindelser. and coating methods, and contains between approx. 0.1 and 75$, especially between approx. 1 and 50% of the active compounds and can, if desired, contain other pharmaceutically active compounds.
De følgende eksempler skal illustrere oppfinnelsen ytterligere, og temperaturene er angitt i celsiusgrader. The following examples shall illustrate the invention further, and the temperatures are indicated in degrees Celsius.
Eksempel 1. Example 1.
En blanding av 10 g a-(4-aminofenyl)-propionsyreetylester-hydroklorid, 15 g a,a'-dibrom-o-xylol, 16,5 g natriumkarbonat og 250 ml dimetylformamid kokes under omrøring og til-bakeløp i 5 timer. Etter avkjøling filtreres, filtratet inndampes under vakuum, fortynnes med.vann og ekstraheres med eter. Det organiske ekstraktet vaskes med vann, tørkes, filtreres og inndampes i vakuum. Bunnfallet frafiltreres, omkrystalliseres fra etanol og opptas i en minimal mengde benzen. Oppløsningen fylles på en liten silikagelkolonne og elueres med benzen. Det første eluatet inndampes og residuumet krystalliseres om fra etanol og gir a- £~4-(2-isoindolino)-feny_l7-propionsyre-etylester A mixture of 10 g of α-(4-aminophenyl)-propionic acid ethyl ester hydrochloride, 15 g of α,α'-dibromo-o-xylene, 16.5 g of sodium carbonate and 250 ml of dimethylformamide is boiled with stirring and refluxed for 5 hours. After cooling, it is filtered, the filtrate is evaporated under vacuum, diluted with water and extracted with ether. The organic extract is washed with water, dried, filtered and evaporated in vacuo. The precipitate is filtered off, recrystallized from ethanol and taken up in a minimal amount of benzene. The solution is loaded onto a small silica gel column and eluted with benzene. The first eluate is evaporated and the residue recrystallized from ethanol to give α-£~4-(2-isoindolino)-phenyl-17-propionic acid ethyl ester
med formel with formula
som smelter ved 111 - 113°C. which melts at 111 - 113°C.
Eksempel 2. Example 2.
En blanding av 1,8 g a-_/~4-(2-isoindolino)-fenyl7-propionsyre-etylester, 5 ml 50%- ig vandig natriumhydroksydopp-løsning, 25 ml vann og 100 ml etanol, kokes 1,5 timer vedtil-bakeløp og konsentreres under nedsatt trykk. Konsentratet fortynnes med vann, suspensjonen surgjøres med 6 N saltsyre til pH = 3 og ekstraheres med eddiksyreetylester. Det organiske ekstrakt tørkes, filtreres og inndampes under nedsatt trykk. Residuumet krystalliseres fra eddiksyreetylester og man får a- A mixture of 1.8 g α-_/~4-(2-isoindolino)-phenyl7-propionic acid ethyl ester, 5 ml 50% aqueous sodium hydroxide solution, 25 ml water and 100 ml ethanol, is boiled for 1.5 hours by reflux and concentrated under reduced pressure. The concentrate is diluted with water, the suspension is acidified with 6 N hydrochloric acid to pH = 3 and extracted with ethyl acetate. The organic extract is dried, filtered and evaporated under reduced pressure. The residue is crystallized from acetic acid ethyl ester and you get a-
som smelter ved 247 - 250°C. which melts at 247 - 250°C.
Eksempel 3- Example 3-
En oppløsning av 0,5 g a-/_ 4-(2-isoindolino)-fenyl/- propionsyre-etylester i 50 ml iseddik tildryppes 6 ml av en mettet oppløsning av klor i iseddik under omrøring, og blandingen inndampes under nedsatt trykk. Residuumet opptas i vandig natriumhydrogenkarbonatoppløsning og ekstraheres med eter, det organiske ekstraktet tørkes, filtreres og inndampes. Inndamp-ningsresten kromatograferes på silikagel med en 1 : 1-blanding av benzen og heksan som bevegelig fase. Som hovedprodukt får man a-/~3-klor-4-(2-isoindolino)-fenyl7-propionsyre-etylester med formel A solution of 0.5 g of a-/_ 4-(2-isoindolino)-phenyl/-propionic acid ethyl ester in 50 ml of glacial acetic acid is added dropwise to 6 ml of a saturated solution of chlorine in glacial acetic acid with stirring, and the mixture is evaporated under reduced pressure. The residue is taken up in aqueous sodium bicarbonate solution and extracted with ether, the organic extract is dried, filtered and evaporated. The evaporation residue is chromatographed on silica gel with a 1:1 mixture of benzene and hexane as mobile phase. As the main product, α-/~3-chloro-4-(2-isoindolino)-phenyl7-propionic acid ethyl ester is obtained with the formula
som har en Rf-verdi på 0,30 (utgangsstoffet: Rf = 0,26), og som sekundærprodukt a-/_ 3,5-diklor-4-(2-isoindolino)-fenyl/-propionsyreetylester med formel which has an Rf value of 0.30 (starting substance: Rf = 0.26), and as a secondary product a-/_ 3,5-dichloro-4-(2-isoindolino)-phenyl/-propionic acid ethyl ester with formula
med Rf = 0,395- with Rf = 0.395-
Eksempel 4. Example 4.
På analog måte kan man under anvendelse av de agnede utgangsstoffer og eventuelt etter ekstra omdannelse fremstille følgende forbindelser: a- r" 3_klor-4- (l^-okso-2-isoindolinyl )-fenyJL7-propionsyreetylester, smeltepunkt 111-113°C, a-/~3-klor-4-(l-okso-2-isoindolinyl)-fenyl7-propionsyre, smeltepunkt 178-l80°C, In an analogous manner, the following compounds can be prepared using the starting materials used and, if necessary, after additional conversion: α-[3-chloro-4-(1-oxo-2-isoindolinyl)-phenyl7-propionic acid, melting point 178-180°C,
a-/_~4-(l-okso-2-isoindolinyl)-fenyl7-propionsyre-mety lester, smelte- α-/_~4-(1-oxo-2-isoindolinyl)-phenyl7-propionic acid methyl ester, melting
punkt 129-132°C, point 129-132°C,
a-/ 4- (l-okso-2-isoindolinyl) -f eny_l7-propionsyre-etylester, smeltepunkt 104-106°C, α-/ 4-(1-oxo-2-isoindolinyl)-phenyl-17-propionic acid ethyl ester, melting point 104-106°C,
a-/_ 4 - (l-okso-2-isoindolinyl) - f eny_l/-propionsyre-n-propylester, smeltepunkt 87-89°C, α-/_ 4 - (1-oxo-2-isoindolinyl)-phenyl_1/-propionic acid-n-propyl ester, melting point 87-89°C,
a-/_ 4- (l-økso-2-isoindolinyl) - fenyl7-propionsyre-isopropylester, smeltepunkt 118-121°CJα-/_ 4-(1-oxo-2-isoindolinyl)-phenyl7-propionic acid isopropyl ester, melting point 118-121°CJ
ot-/~4- (l-okso-2-isoindolinyl)-fenyl7-propionsyre-isobutylester, smeltepunkt 110-113°C, ot-/~4-(1-oxo-2-isoindolinyl)-phenyl7-propionic acid isobutyl ester, melting point 110-113°C,
a-/_ 3~klor-4-(2-isoindolinyl)- feny3.7-propionsyre-etylester, smeltepunkt 67-70°C og kokepunkt 190-200°C/0,4 mm Hg. a-/_ 3~Chloro-4-(2-isoindolinyl)-phenyl3,7-propionic acid ethyl ester, melting point 67-70°C and boiling point 190-200°C/0.4 mm Hg.
Eksempel 5 - Example 5 -
En blanding av 0,25 g magnesium, 10 ml tetrahydrofuran og 1 dråpe metyljodid blandes under omrøring dråpevis med en oppløsning av 3 g a- £~4-(2-isoindolinyl)-fenyl7-etyl-bromid i 5 ml tetrahydrofuran og blandingen kokes under tilbake-løp til reaksjonens opphør. Deretter lar man under kraftig om-røring i 5 minutter ved 0°C gjennomboble karbondioksyd, fortynner med vann, innstiller pH-verdien med saltsyre til 4 og ekstraherer med dietyleter. Det organiske ekstrakt tørkes og inndampes-. Residuet omkrystalliseres fra eddiksyreetylester og gir <x-/"~2t (4-isoindolinyl)-feny_l/-propionsyre, smeltepunkt 247-250°C. A mixture of 0.25 g of magnesium, 10 ml of tetrahydrofuran and 1 drop of methyl iodide is mixed dropwise with stirring with a solution of 3 g of α-£~4-(2-isoindolinyl)-phenyl7-ethyl bromide in 5 ml of tetrahydrofuran and the mixture is boiled during return until the reaction ceases. Carbon dioxide is then allowed to bubble through with vigorous stirring for 5 minutes at 0°C, diluted with water, adjusted to pH 4 with hydrochloric acid and extracted with diethyl ether. The organic extract is dried and evaporated. The residue is recrystallized from acetic acid ethyl ester and gives <x-/"~2t (4-isoindolinyl)-phenyl_1/-propionic acid, melting point 247-250°C.
Utgangsmaterialet kan fremstilles på følgende måte: En oppløsning av 2,4 g 4-(2-isoindolinyl)-acetofenon i 30 ml etanol blandes med 0,75 g natriumborhydrid og kokes under til-bakeløp i 2 timer, fortynnes deretter med vann og inndampes under nedsatt trykk. Man fortynner igjen med vann og ekstraherer med dietyleter, det organiske ekstrakt tørkes og inndampes under nedsatt trykk. Man får således a-/_ 4-(2-is'oindolinyl)-fenyl/- etanol. The starting material can be prepared as follows: A solution of 2.4 g of 4-(2-isoindolinyl)-acetophenone in 30 ml of ethanol is mixed with 0.75 g of sodium borohydride and refluxed for 2 hours, then diluted with water and evaporated under reduced pressure. Dilute again with water and extract with diethyl ether, the organic extract is dried and evaporated under reduced pressure. Thus α-/_ 4-(2-isoindolinyl)-phenyl/- ethanol is obtained.
En oppløsning av 2,5 g a-/_ 4-(2-isoindolinyl)-fenyl7-etanol i 20 ml benzen behandles med 0,43 g fosforpentaklorid op blandingen kokes i 2 timer under tilbakeløp og avkjøles. Man vasker med vann, tørker og inndamper under nedsatt trykk. Man får således ot-/~4- (2-isoindolinyl)-f eny3/7-etylbromid, som videreforarbeides uten rensning. A solution of 2.5 g α-/_ 4-(2-isoindolinyl)-phenyl7-ethanol in 20 ml benzene is treated with 0.43 g phosphorus pentachloride and the mixture is boiled for 2 hours under reflux and cooled. Wash with water, dry and evaporate under reduced pressure. One thus obtains ot-[4-(2-isoindolinyl)-pheny3/7-ethyl bromide, which is further processed without purification.
Eksempel 6. Example 6.
En blanding av 2,7 g N,N-dimetyl-N-a-/~4-(2-isoindolinyl)-fenyl7-etylamin, 1,6 g metyljodid og 30 ml .vannfri etanol kokes i 15 minutter under tilbakeløp og fortynnes med dietyleter. Utfellingen inneholdende N,N,N-trimetyl-N-a-/~4-(2-isoindolinyl)-fenyl/-etyl-ammoniumjodid, frafiltreres og oppløses i den mini-male mengde 50#-ige vandige etanol. Oppløsningen blandes med 6,6 g kaliumcyanid, blandingen oppvarmes i 8 timer ved l60°C i et lukket kar. Etter avkjøling ekstraheres med dietyleter, det organiske ekstrakt tørkes, filtreres og inndampes. Man får således a-_/~4-(2-isoindolinyl)-f enyl7-propionitril. Infrarødt absorbsjonsspektrum: fremstående bånd ved 2110 cm ^. A mixture of 2.7 g of N,N-dimethyl-N-a-/~4-(2-isoindolinyl)-phenyl7-ethylamine, 1.6 g of methyl iodide and 30 ml of anhydrous ethanol is boiled for 15 minutes under reflux and diluted with diethyl ether . The precipitate containing N,N,N-trimethyl-N-a-/~4-(2-isoindolinyl)-phenyl/-ethyl-ammonium iodide is filtered off and dissolved in the minimum amount of 50% aqueous ethanol. The solution is mixed with 6.6 g of potassium cyanide, the mixture is heated for 8 hours at 160°C in a closed vessel. After cooling, extract with diethyl ether, the organic extract is dried, filtered and evaporated. One thus obtains α-_/~4-(2-isoindolinyl)-phenyl7-propionitrile. Infrared absorption spectrum: prominent band at 2110 cm^.
Overnevnte produkt opptas i 25 ml etylenglykol og The above-mentioned product is taken up in 25 ml of ethylene glycol and
9 ml av en 50^-ig vandig natriumhydroksydoppløsning og blandingen kokes i 24 timer under tilbakeløp. Man avkjøler, fortynner med vann, vasker med dietyleter og innstiller med pH med saltsyre til 4. Man ekstraherer med eddiksyreetylester, det organiske ekstrakt tørkes, filtreres og inndampes og residuet omkrystalliseres fra eddiksyreetylester. Man får således ct-£~4-(2-isoindolinyl)-fenyl7-propionsyre, smeltepunkt 247-250°C. 9 ml of a 50 µg aqueous sodium hydroxide solution and the mixture is boiled for 24 hours under reflux. Cool, dilute with water, wash with diethyl ether and adjust the pH with hydrochloric acid to 4. One extracts with acetic acid ethyl ester, the organic extract is dried, filtered and evaporated and the residue is recrystallized from acetic acid ethyl ester. One thus obtains ct-£~4-(2-isoindolinyl)-phenyl7-propionic acid, melting point 247-250°C.
Utgangsmaterialet kan fremstilles på følgende måte: En oppløsning av 2,4 g 4-(2-isoindolinyl)-acetonfenon i 30 ml etanol blandes med 0,75 g natriumborhydrid og kokes under til-bakeløp i 2 timer, fortynnes deretter med vann og inndampes under nedsatt trykk. Man fortynner igjen med vann og ekstraherer med dietyleter, det organiske ekstrakt tørkes og inndampes under nedsatt trykk. Man får således a-/<->4-(2-isoindolinyl)-f eny_l/-etanol. The starting material can be prepared as follows: A solution of 2.4 g of 4-(2-isoindolinyl)-acetonephenone in 30 ml of ethanol is mixed with 0.75 g of sodium borohydride and refluxed for 2 hours, then diluted with water and evaporated under reduced pressure. Dilute again with water and extract with diethyl ether, the organic extract is dried and evaporated under reduced pressure. One thus obtains α-[<->4-(2-isoindolinyl)-phenyl]-ethanol.
En oppløsning av 2,5 g a-/~4-(2-isoindolinyl)-fenyl7-.etanol i 20 ml benzen behandles med 0,43 g fosforpentaklorid og blandingen kokes i 2 timer under tilbakeløp og avkjøles. Man vasker med vann, tørker og inndamper under nedsatt trykk. Man får således a-/<->4-(2-isoindolinyl)-feny_l7-etylbromid, som videreforarbeides uten rensning. A solution of 2.5 g of α-[4-(2-isoindolinyl)-phenyl]-ethanol in 20 ml of benzene is treated with 0.43 g of phosphorus pentachloride and the mixture is boiled for 2 hours under reflux and cooled. Wash with water, dry and evaporate under reduced pressure. One thus obtains α-[<->4-(2-isoindolinyl)-phenyl-17-ethyl bromide, which is processed further without purification.
En blanding av 3 g a-/_—4-(2-isoindolinyl)-f enyl7-etylbromid, 4,1 g dimetylamin-hydroklorid og 12 ml trietylamin oppvarmes i 3 timer i et lukket kar ved 100°C. Man avkjøler og filtrerer, filtratet inndampes under nedsatt trykk. Konsentratet fortynnes med en vandig natriumhydroksydoppløsning og ekstraheres med dietyleter. Det organiske ekstrakt Cørkes og det inndampes under nedsatt trykk. Man får således N,N-dimetyl-N-a-/~4- (2-isoindolinyl) - f eny_l7-etylamin. A mixture of 3 g of α-(2-isoindolinyl)-phenyl-7-ethyl bromide, 4.1 g of dimethylamine hydrochloride and 12 ml of triethylamine is heated for 3 hours in a closed vessel at 100°C. It is cooled and filtered, the filtrate is evaporated under reduced pressure. The concentrate is diluted with an aqueous sodium hydroxide solution and extracted with diethyl ether. The organic extract is dried and evaporated under reduced pressure. N,N-dimethyl-N-a-[4-(2-isoindolinyl)-phenyl]-ethylamine is thus obtained.
Eksempel7. Example 7.
En blanding av 5 g 2-_/ 4-(2-isoindolinyl)-feny_l/- propanol, 4 g natriumhydroksyd og 50 ml vann haes under omrøring til en suspensjon av 6,5 g sølvnitrat, 1,8 g natriumhydroksyd og 60 ml vann. Etter 3 timer filtreres blandingen, filtratets pH innstilles med saltsyre til 5,5 og ekstraheres med dietyleter. Det organiske ekstrakt vaskes med vann, filtreres og inndampes. Residuet omkrystalliseres fra eddiksyreetylester, A mixture of 5 g of 2-_/ 4-(2-isoindolinyl)-phenyl_1/- propanol, 4 g of sodium hydroxide and 50 ml of water is stirred into a suspension of 6.5 g of silver nitrate, 1.8 g of sodium hydroxide and 60 ml water. After 3 hours, the mixture is filtered, the pH of the filtrate is adjusted to 5.5 with hydrochloric acid and extracted with diethyl ether. The organic extract is washed with water, filtered and evaporated. The residue is recrystallized from acetic acid ethyl ester,
man får således a-/~4-(2-isoindolinyl)-feny].7-propionsyre, smeltepunkt 247-250°C. one thus obtains α-/~4-(2-isoindolinyl)-phenyl].7-propionic acid, melting point 247-250°C.
Utgangsmaterialet kan fremstilles på følgende måte: The starting material can be produced in the following way:
En oppløsning av 89 g 4-acetylamino-acetofenon i A solution of 89 g of 4-acetylamino-acetophenone i
200 ml tetrahydrofuran haes dråpevis i en nitrogenatmosfære til en magnesiumjodidoppløsning, dannet av 13,4 g magnesium og 78,1 g metyljodid i 300 ml tetrahydrofuran. Reaksjonsblandingen kokes i 18 timer under tilbakeløp og blandes etter avkjøling med 200 ml 10%-ig vandig saltsyre, man oppvarmer i to ytterligere timer, inndamper deretter og opptar residuet i vann. Blandingen ekstraheres med dietyleter og det organiske ekstrakt tørkes og inndampes. Residuet blandes med 100 ml eddiksyreanhydrid og oppvarmes på dampbadet i en time. Oppløsningsmidlet avdampes azeo-tropt sammen med toluen og man får således 2-(4-acetylamino-fenyl)-propen. 200 ml of tetrahydrofuran is added dropwise in a nitrogen atmosphere to a magnesium iodide solution, formed from 13.4 g of magnesium and 78.1 g of methyl iodide in 300 ml of tetrahydrofuran. The reaction mixture is boiled for 18 hours under reflux and, after cooling, is mixed with 200 ml of 10% aqueous hydrochloric acid, heated for a further two hours, then evaporated and the residue taken up in water. The mixture is extracted with diethyl ether and the organic extract is dried and evaporated. The residue is mixed with 100 ml of acetic anhydride and heated on the steam bath for one hour. The solvent is azeotropically evaporated together with toluene and thus 2-(4-acetylamino-phenyl)-propene is obtained.
En oppløsning av 67 g 2-(4-acetylamino-fenyl)-propen A solution of 67 g of 2-(4-acetylamino-phenyl)-propene
i 100 ml dietylenglykol-dimetyleter blandes ved 0°C og under en nitrogenatmosfære med en blanding av 15 g natriumborhydrid, 61 g bortrifluorid-dietyleterat og 100 ml dietylenglykolmetyleter. Blandingen oppvarmes til 25°C, omrøres i 2 timer og blandes med isstykker. Man tilsetter 100 ml av en 3 N vandig natriumhydrok-sydoppløsning, blander i løpet av en time med 50 ml av en 30^-ig vandig hydrogensuperoksydoppløsning og omrører i 2 timer ved værelsestemperatur. Sjiktene adskilles, den vandige fase ekstraheres med dietyleter og de forenede organiske oppløsninger inndampes under nedsatt trykk. Man oppløser residuet i 100 ml etanol og tilsetter 100 ml av en 3 N vandig natriumhydroksydoppløs-ning, koker blandingen i 2 timer under tilbakeløp, avkjøler og ekstraherer med dietyleter. Det organiske ekstrakt tørkes og inndampes og gir 2-(4-amino-fenyl)-propanol. in 100 ml diethylene glycol dimethyl ether is mixed at 0°C and under a nitrogen atmosphere with a mixture of 15 g sodium borohydride, 61 g boron trifluoride diethyl etherate and 100 ml diethylene glycol methyl ether. The mixture is heated to 25°C, stirred for 2 hours and mixed with ice cubes. 100 ml of a 3 N aqueous sodium hydroxide solution is added, mixed over the course of an hour with 50 ml of a 30% aqueous hydrogen peroxide solution and stirred for 2 hours at room temperature. The layers are separated, the aqueous phase is extracted with diethyl ether and the combined organic solutions are evaporated under reduced pressure. The residue is dissolved in 100 ml of ethanol and 100 ml of a 3 N aqueous sodium hydroxide solution is added, the mixture is boiled for 2 hours under reflux, cooled and extracted with diethyl ether. The organic extract is dried and evaporated to give 2-(4-amino-phenyl)-propanol.
En blanding av 15,1 g 2-(4-amino-fenyl)-propanol, A mixture of 15.1 g of 2-(4-amino-phenyl)-propanol,
26,4 g a,a'-dibrom-o-xylen, 30 g natriumkarbonat og 200 ml dimetylformamid oppvarmes under omrøring i 4 timer ved 100°C. Etter avkjøling filtreres, filtratet inndampes under nedsatt 26.4 g of a,a'-dibromo-o-xylene, 30 g of sodium carbonate and 200 ml of dimethylformamide are heated with stirring for 4 hours at 100°C. After cooling, filter, the filtrate is evaporated under reduced pressure
trykk og fortynnes med vann. Man ekstraherer med dietyleter, vasker det organiske ekstrakt med vann, tørker og inndamper. pressure and dilute with water. Extract with diethyl ether, wash the organic extract with water, dry and evaporate.
Man får således 2- 1_ 4-(2-isoindolinyl)-feny_l7-propanol. Eksempel 8. 2-1-4-(2-isoindolinyl)-phenyl-17-propanol is thus obtained. Example 8.
En blanding av 5 g cc-/_ 4-(2-isoindolinyl)-fenyl7-a-jnetyl-malonsyre-dietylester, 50 ml etanol og 40 ml av en 25%-ig vandig kaliumhydroksyloppløsning kokes i 4 timer under tilbake-løp og inndampes under nedsatt trykk. Residuet opptas i 50^-ig vandig svovelsyre og blandingen oppvarmes på dampbad i 10 minutter, pH-verdien innstilles med vandig natriumhydroksydoppløs-ning på 4 og ekstraheres med dietyleter. Det organiske ekstrakt vaskes med vann, tørkes og inndampes. Residuet omkrystalliseres fra eddiksyreetylester og man får således 2-/~4-(2-isoindolinyl)-feny_l7-propionsyre, smeltepunkt 247-250°C. A mixture of 5 g of cc-/_ 4-(2-isoindolinyl)-phenyl7-a-jnethyl-malonic acid diethyl ester, 50 ml of ethanol and 40 ml of a 25% aqueous potassium hydroxide solution is boiled for 4 hours under reflux and evaporated under reduced pressure. The residue is taken up in 50 µg aqueous sulfuric acid and the mixture is heated on a steam bath for 10 minutes, the pH is adjusted to 4 with aqueous sodium hydroxide solution and extracted with diethyl ether. The organic extract is washed with water, dried and evaporated. The residue is recrystallized from acetic acid ethyl ester and 2-[4-(2-isoindolinyl)-phenyl-17-propionic acid is thus obtained, melting point 247-250°C.
Utgangsmaterialet kan fremstilles på følgende måte: En blanding av 25 g 4-klornitrobenzen, 12,6 g av en 50#-ig suspensjon av natriumhydrid i mineralolje, 50 g a-metyl-malonsyre-dietylester og 150 ml heksametyl-fosfortriamid oppvarmes i 2\ dag ved 100°C. Etter avkjøling helles det ut på vann og ekstraheres med dietyleter, ekstraktet tørkes og inndampes og gir a-metyl-a-(4-nitrofenyl)-malonsyre-dietylester. The starting material can be prepared as follows: A mixture of 25 g of 4-chloronitrobenzene, 12.6 g of a 50% suspension of sodium hydride in mineral oil, 50 g of a-methyl-malonic acid diethyl ester and 150 ml of hexamethyl-phosphorus triamide is heated for 2 \ day at 100°C. After cooling, it is poured onto water and extracted with diethyl ether, the extract is dried and evaporated to give α-methyl-α-(4-nitrophenyl)-malonic acid diethyl ester.
En oppløsning av 28 g a-metyl-a-(4-nitrofenyl)-malon-syre-dietylester i 150-.ml av en mettet oppløsning av klorhydro-gen i etanol blandes med 1,5 g av en 10#-ig palladium-på-kull-katalysator og hydreres ved 3 atmosfæreres trykk. Etter opphor av hydrogenopptaket frafiltreres katalysatoren, filtratet inndampes under nedsatt trykk og residuet opptas i vann. Blandingen gjøres basisk med en vandig natriumhydroksydoppløsning og ekstraheres med dietyleter. Det organiske ekstrakt tørkes og inndampes, man får således ot-(4-aminofenyl)-a-metyl-malonsyre-dietylester. A solution of 28 g of α-methyl-α-(4-nitrophenyl)-malonic acid diethyl ester in 150 ml of a saturated solution of hydrogen chloride in ethanol is mixed with 1.5 g of a 10# palladium -on-charcoal catalyst and is hydrated at 3 atmospheres of pressure. After the hydrogen absorption has ceased, the catalyst is filtered off, the filtrate is evaporated under reduced pressure and the residue is taken up in water. The mixture is basified with an aqueous sodium hydroxide solution and extracted with diethyl ether. The organic extract is dried and evaporated, thus obtaining ot-(4-aminophenyl)-a-methyl-malonic acid diethyl ester.
En blanding av 5 g ot- (4-aminofen<y>l)-a-metyl-malon-syre-dietylester, 5,3 g a,a'-dibrom-o-xylen, 5 g natriumkarbonat og 120 ml dimetylformamid oppvarmes i 5 timer under omrøring ved 100°C. Etter avkjøling filtreres, filtratet inndampes under nedsatt trykk, konsentratet fortynnes med vann og ekstraheres med dietyleter. Det organiske ekstrakt vaskes med vann, tørkes A mixture of 5 g of ot-(4-aminophen<y>l)-α-methyl-malonic acid diethyl ester, 5.3 g of α,α'-dibromo-o-xylene, 5 g of sodium carbonate and 120 ml of dimethylformamide is heated in 5 hours with stirring at 100°C. After cooling, it is filtered, the filtrate is evaporated under reduced pressure, the concentrate is diluted with water and extracted with diethyl ether. The organic extract is washed with water, dried
og inndampes. Man får således ot-/<->4-(2-isoindolinyl)-feny_l7-malonsyre-dietylester. and evaporated. One thus obtains o-[<->4-(2-isoindolinyl)-phenyl-17-malonic acid diethyl ester.
Eksempel 9- Example 9-
En blanding av 10 g a-(4-aminofenyl)-propionsyreetylester-hydroklorid, 15 g a,a'-dibrom-o-xylen, 16,5 g natriumkarbonat og 250 ml dimetylformamid kokes unåer omrøring og tiln bakeløp i 5 timer. Etter avkjøling filtreres, filtratet inndampes under nedsatt trykk, fortynnes med vann og ekstraheres med eter. Det organiske ekstrakt vaskes med vann, tørkes, filtreres og inndampes under nedsatt trykk. Utfellingen frafiltreres, omkrystalliseres fra etanol og opptas i en minimal ben-zenmengde. Oppløsningen opptrekkes på en liten søyle med silikagel og elueres med benzen. Det første eluat inndampes og residuet omkrystalliseres fra etanol og man får således a- £~ h-(2-isoindolinyl)-feny_l/-propionsyre-etylester med formel A mixture of 10 g of α-(4-aminophenyl)-propionic acid ethyl ester hydrochloride, 15 g of α,α'-dibromo-o-xylene, 16.5 g of sodium carbonate and 250 ml of dimethylformamide is boiled without stirring and refluxed for 5 hours. After cooling, it is filtered, the filtrate is evaporated under reduced pressure, diluted with water and extracted with ether. The organic extract is washed with water, dried, filtered and evaporated under reduced pressure. The precipitate is filtered off, recrystallized from ethanol and taken up in a minimal amount of benzene. The solution is drawn up on a small column of silica gel and eluted with benzene. The first eluate is evaporated and the residue is recrystallized from ethanol and one thus obtains α-£~ h-(2-isoindolinyl)-phenyl-1/-propionic acid ethyl ester of the formula
som smelter ved 111-113°C. which melts at 111-113°C.
Eksempel 10. Example 10.
En oppløsning av 27,3 g 2-(4-bromfenyl)-isoindolin i A solution of 27.3 g of 2-(4-bromophenyl)-isoindoline i
25 ml dietyleter haes dråpevis under omrøring i en nitrogenatmosfære til en suspensjon av 1,4 g litium i 100 ml dietyleter. Etter forbruk av litium filtreres blandingen gjennom glassull og filtratet haes dråpevis under omrøring i en nitrogenatmosfære til en oppløsning av 18 g a-brom-propionsyreetylester i 100 ml dietyleter. Etter 3 timers koking under tilbakeløp behandles med 100 ml av en mettet, vandig ammoniumkloridoppløsning, den organiske oppløsning adskilles, tørkes og inndampes. Residuet krystalliseres fra etanol og gir a-/~4-(2-isoindolinyl)-feny_l7-propionsyreetylester, smeltepunkt 111-113°C. 25 ml of diethyl ether are added dropwise with stirring in a nitrogen atmosphere to a suspension of 1.4 g of lithium in 100 ml of diethyl ether. After consumption of lithium, the mixture is filtered through glass wool and the filtrate is added dropwise with stirring in a nitrogen atmosphere to a solution of 18 g of α-bromo-propionic acid ethyl ester in 100 ml of diethyl ether. After boiling under reflux for 3 hours, treat with 100 ml of a saturated, aqueous ammonium chloride solution, the organic solution is separated, dried and evaporated. The residue is crystallized from ethanol and gives α-[4-(2-isoindolinyl)-phenyl]-propionic acid ethyl ester, melting point 111-113°C.
Utgangsmaterialet kan fremstilles som følger: En blanding av 5 g 4-bromanilin, 8 g ct,a'-dibrom-o-xylen, 9 g natriumkarbonat og 130 ml dimetylformamid kokes under omrøring i 5 timer under tilbakeløp. Etter avkjøling inndampes under nedsatt trykk og konsentratet fortynnes med vann og ekstraheres med dietyleter. Det organiske ekstrakt vaskes med vann, tørkes og inndampes, det således dannede 2-(4-bromfenyl)-isoindolin videreforarbeides uten rensning. The starting material can be prepared as follows: A mixture of 5 g of 4-bromoaniline, 8 g of ct,a'-dibromo-o-xylene, 9 g of sodium carbonate and 130 ml of dimethylformamide is boiled with stirring for 5 hours under reflux. After cooling, it is evaporated under reduced pressure and the concentrate is diluted with water and extracted with diethyl ether. The organic extract is washed with water, dried and evaporated, the 2-(4-bromophenyl)-isoindoline thus formed is further processed without purification.
Eksempel 11. Example 11.
En blanding av 22,8 g etyl a-(4-amino-3-klorfenyl)-propionat, 19,8 g etyl 2-klormetylbenzoat, 15 ml trietylamin og ^OO ml <p>tannl hensettes naht<p>n nv<p>r ner fn-prtamnps 1 nnersnmf.. R<p>si-duet opptas i vann, blandingen ekstraheres med dietyleter, ekstraktet vaskes med 5% saltsyre og vann, tørkes, filtreres og fordampes. Residuet opptas i 250 ml etanol, 100 ml 10$ vandig kaliumkarbonat tilsettes og blandingen fordampes langsomt i vakuum. Residuet opptas i vann, oppløsningen filtreres, filtratets pH justeres til 4 med saltsyre og ekstraheresmed etylacetat. Ekstraktet vaskes med vann, tørkes, og konsentreres for å gi a-/<_>—3-klor-4-(l-okso-isoindolino;-fenyl7-propionsyre med formel A mixture of 22.8 g of ethyl α-(4-amino-3-chlorophenyl)-propionate, 19.8 g of ethyl 2-chloromethylbenzoate, 15 ml of triethylamine and 100 ml of <p>tannl is prepared overnight p>r ner fn-prtamnps 1 nnersnmf.. The R<p>sidue is taken up in water, the mixture is extracted with diethyl ether, the extract is washed with 5% hydrochloric acid and water, dried, filtered and evaporated. The residue is taken up in 250 ml of ethanol, 100 ml of 10% aqueous potassium carbonate is added and the mixture is slowly evaporated in vacuo. The residue is taken up in water, the solution is filtered, the pH of the filtrate is adjusted to 4 with hydrochloric acid and extracted with ethyl acetate. The extract is washed with water, dried, and concentrated to give α-[<_>—3-chloro-4-(1-oxo-isoindolino;-phenyl7-propionic acid of formula
Smeltepunkt ved l6l-l63°C. Melting point at l6l-l63°C.
Etylesteren herav koker ved 200-210°C70,4 mm Hg. Eksempel 12. The ethyl ester thereof boils at 200-210°C70.4 mm Hg. Example 12.
En blanding av 7,9 g etyl a-(4-aminofenyl)-propiohat og 8,3 g etyl 2-klormetylbenzoat tilbakeløpskokes under nitrogen i 1 time. Residuet omkrystalliseres fra heksan for å gi etyl a-jf~4-(1-oksoisoindolino)-fenyl7-propionat med formel A mixture of 7.9 g of ethyl α-(4-aminophenyl)-propioate and 8.3 g of ethyl 2-chloromethylbenzoate is refluxed under nitrogen for 1 hour. The residue is recrystallized from hexane to give ethyl α-jf~4-(1-oxoisoindolino)-phenyl7-propionate of the formula
Smeltepunkt 104-106°C. Melting point 104-106°C.
En blanding av 4,5 g herav, 1,6 g kaliumhydroksyd, A mixture of 4.5 g of this, 1.6 g of potassium hydroxide,
2 ml vann og 250 ml etanol tilbakeløpskokes under nitrogen i 2 ml of water and 250 ml of ethanol are refluxed under nitrogen i
2 timer og fordampes under nedsatt trykk. Residuet opptas i vann, oppløsningen vaskes med kloroform, surgjøres med saltsyre og ekstraheres med etylacetat. Ekstraktet tørkes, fordampes og residuet omkrystalliseres fra etylacetat, for å gi den tilsvarende fri syre med smeltepunkt 208-210°C, 2 hours and evaporate under reduced pressure. The residue is taken up in water, the solution is washed with chloroform, acidified with hydrochloric acid and extracted with ethyl acetate. The extract is dried, evaporated and the residue recrystallized from ethyl acetate to give the corresponding free acid with a melting point of 208-210°C,
På analog måte fremstilles etyl 4-(1-oksoisoindolino)-fenylacetat, smeltepunkt lll-ll4°C og den tilsvarende fri syre med smeltepunkt 206-208°C, Ethyl 4-(1-oxoisoindolino)-phenylacetate, melting point 11-114°C and the corresponding free acid with melting point 206-208°C are prepared in an analogous manner,
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84324469A | 1969-07-18 | 1969-07-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO135938B true NO135938B (en) | 1977-03-21 |
NO135938C NO135938C (en) | 1977-06-29 |
Family
ID=25289436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO3751/69A NO135938C (en) | 1969-07-18 | 1969-09-19 |
Country Status (8)
Country | Link |
---|---|
CH (13) | CH577480A5 (en) |
ES (1) | ES381910A2 (en) |
FI (1) | FI54106C (en) |
NO (1) | NO135938C (en) |
PL (6) | PL116729B1 (en) |
SE (1) | SE394670B (en) |
SU (1) | SU520040A3 (en) |
ZA (1) | ZA704666B (en) |
-
1969
- 1969-09-12 CH CH1383169A patent/CH577480A5/en not_active IP Right Cessation
- 1969-09-12 CH CH935375A patent/CH577482A5/xx not_active IP Right Cessation
- 1969-09-12 CH CH935275A patent/CH577481A5/xx not_active IP Right Cessation
- 1969-09-17 SE SE6912776A patent/SE394670B/en unknown
- 1969-09-19 NO NO3751/69A patent/NO135938C/no unknown
- 1969-09-25 FI FI2750/69A patent/FI54106C/en active
-
1970
- 1970-03-16 PL PL1970219917A patent/PL116729B1/en unknown
- 1970-03-16 PL PL1970219921A patent/PL116578B1/en unknown
- 1970-03-16 PL PL1970219916A patent/PL116504B1/en unknown
- 1970-03-16 PL PL1970139442A patent/PL97082B3/en unknown
- 1970-07-07 ZA ZA704666A patent/ZA704666B/en unknown
- 1970-07-16 PL PL1970187953A patent/PL99354B1/en unknown
- 1970-07-16 ES ES381910A patent/ES381910A2/en not_active Expired
- 1970-07-16 PL PL1970187954A patent/PL99355B1/en unknown
-
1974
- 1974-05-28 SU SU2027897A patent/SU520040A3/en active
-
1975
- 1975-07-16 CH CH1383169A patent/CH585725A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH585724A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH935475A patent/CH605792A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH585723A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH584690A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH585727A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH579548A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH585726A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH579541A5/xx not_active IP Right Cessation
- 1975-07-16 CH CH1383169A patent/CH585722A5/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SU520040A3 (en) | 1976-06-30 |
CH605792A5 (en) | 1978-10-13 |
PL116578B1 (en) | 1981-06-30 |
CH579541A5 (en) | 1976-09-15 |
CH577480A5 (en) | 1976-07-15 |
CH585724A5 (en) | 1977-03-15 |
CH577482A5 (en) | 1976-07-15 |
SE394670B (en) | 1977-07-04 |
CH585726A5 (en) | 1977-03-15 |
CH585725A5 (en) | 1977-03-15 |
CH585723A5 (en) | 1977-03-15 |
CH584690A5 (en) | 1977-02-15 |
FI54106C (en) | 1978-10-10 |
ES381910A2 (en) | 1973-01-16 |
CH585727A5 (en) | 1977-03-15 |
PL99354B1 (en) | 1978-07-31 |
PL116504B1 (en) | 1981-06-30 |
NO135938C (en) | 1977-06-29 |
PL116729B1 (en) | 1981-06-30 |
CH585722A5 (en) | 1977-03-15 |
PL97082B3 (en) | 1978-02-28 |
CH579548A5 (en) | 1976-09-15 |
PL99355B1 (en) | 1978-07-31 |
ZA704666B (en) | 1971-03-31 |
FI54106B (en) | 1978-06-30 |
CH577481A5 (en) | 1976-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3484445A (en) | Derivatives of chromone-2-carboxylic acid | |
US4057573A (en) | New hydroaromatic compounds | |
US3953490A (en) | Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile | |
US3362988A (en) | Alkanoylnaphthyloxy-carboxylic acids | |
US3880916A (en) | Cycloaliphatic acids | |
US3786085A (en) | Aryl substituted cycloaliphatic acids | |
NO135938B (en) | ||
SU856382A3 (en) | Method of preparing cynnolin-3-yl-carboxalic acids or their salts | |
US4219657A (en) | Dibenzothiophenes | |
US4393008A (en) | 2-Cyano-2-(3-phenoxy-phenyl)-propionic acid amide and preparation thereof | |
US3936467A (en) | Hydroxyalkylenimino-phenyl-acetic acids | |
US3301859A (en) | Cinchoninic acids and use in process for quinolinols | |
NO142218B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE AMINE DERIVATIVES | |
SU764609A3 (en) | Method of preparing benzimidazolecarbamate derivatives | |
NO137201B (en) | ANALOGICAL PROCEDURES FOR THE PREPARATION OF NEW, SUBSTITUTED XANTON CARBOXYLIC ACID COMPOUNDS WITH PROPHYLATIC AND THERAPEUTIC EFFECT | |
EP0000152B1 (en) | Oxaminic acids and esters, process for their preparation and pharmaceutical compositions containing them | |
NO131507B (en) | ||
US3291805A (en) | Method for the production of hydroxypicolinic acid | |
JPS6051463B2 (en) | (2-Fluoro-4-biphenylyl)ketene mercaptal S-oxides | |
NO171499B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6-DIHYDRO-4H-CYCLO-PENTA (B) THIOFEN-6-CARBOXYLIC ACID DERIVATIVES | |
US4029664A (en) | Process for interconversion of heteroyohimbane alkaloids | |
US3598861A (en) | 2-(5'-phenyl-m-terphenyl - 4 - yloxy) lower aliphatic monocarbocyclic acids and esters thereof | |
US3962342A (en) | Bromination process | |
US3320306A (en) | Process for the preparation of 4-(2-methylenealkanoyl)phenoxy alkanoic acids by decarboxylation | |
NO137546B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE BIPHENYLPROPIONIC ACIDS AND THEIR DERIVATIVES |